Low-dose adriamycin remission maintenance therapy for pediatric solid tumors
- 1 June 1977
- Vol. 39 (6) , 2411-2414
- https://doi.org/10.1002/1097-0142(197706)39:6<2411::aid-cncr2820390616>3.0.co;2-3
Abstract
A low-dose maintenance schedule of Adriamycin was evaluated in six children whose metastatic solid tumors regressed following toxic induction therapy with Adriamycin. Three of these children are now disease-free more than one year following discontinuation of therapy. Adriamycin can be given on a low-dose maintenance schedule free from alopecia, fever, stomatitis, myelosuppression and recognizable cardiomyopathy. Further studies of similar schedules are warranted.This publication has 13 references indexed in Scilit:
- Adriamycin: A new effective agent in the therapy of disseminated sarcomasMedical and Pediatric Oncology, 1975
- AdriamycinAnnals of Internal Medicine, 1974
- Teratomas in children: Clinical and pathologic aspectsJournal of Pediatric Surgery, 1972
- Preliminary Data on the Treatment of Hemoblastoses with AdriamycinPublished by Springer Nature ,1972
- Adriamycin Use in Solid Tumors and in Lymphoblastic Leukemia of ChildrenPublished by Springer Nature ,1972
- Adriamycin in Children with Acute Leukemia and Other Neoplastic DiseasesPublished by Springer Nature ,1972
- Clinical Trials with Adriamycin. Results of Three-Years StudyPublished by Springer Nature ,1972
- Embryonal adenocarcinomas (a type of malignant teratoma) of the sacrococcygeal region.Clinical and pathologic aspects of 21 casesCancer, 1970
- Clinical Evaluation of Adriamycin, a New Antitumour AntibioticBMJ, 1969
- Teratomata in infancy and childhood: A review of 91 casesThe Journal of Pathology, 1969